Patents by Inventor Donna Morris

Donna Morris has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies against CTLA4 and uses therefor
    Publication number: 20060165706
    Abstract: The invention provides an antibody-toxic moiety conjugates comprising an antibody that specifically recognizes a molecule expressed on the surface of a T cell which is expressed only on T cells and is only expressed transiently on T cells upon T cell activation. Preferably, the T cell molecule is CTLA4. The invention further provides anti-CTLA4 antibodies and humanized forms thereof.
    Type: Application
    Filed: December 29, 2005
    Publication date: July 27, 2006
    Applicant: Genetics Institute, LLC
    Inventors: Beatriz Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary Gray, Donna Morris, Denise O'Hara, Paul Hinton, Naoya Tsurushita
  • Antibodies against CTLA4
    Patent number: 7034121
    Abstract: The invention provides an antibody-toxic moiety conjugates comprising an antibody that specifically recognizes a molecule expressed on the surface of a T cell which is expressed only on T cells and is only expressed transiently on T cells upon T cell activation. Preferably, the T cell molecule is CTLA4. The invention further provides anti-CTLA4 antibodies and humanized forms thereof.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: April 25, 2006
    Assignee: Genetics Institue, LLC
    Inventors: Beatriz M. Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary S. Gray, Donna Morris, Denise O'Hara, Paul R. Hinton, Naoya Tsurushita
  • Antibodies against CTLA4 and uses therefor
    Publication number: 20020039581
    Abstract: The invention provides an antibody-toxic moiety conjugates comprising an antibody that specifically recognizes a molecule expressed on the surface of a T cell which is expressed only on T cells and is only expressed transiently on T cells upon T cell activation. Preferably, the T cell molecule is CTLA4. The invention further provides anti-CTLA4 antibodies and humanized forms thereof.
    Type: Application
    Filed: January 26, 2001
    Publication date: April 4, 2002
    Inventors: Beatriz M. Carreno, Clive Wood, Katherine Turner, Mary Collins, Gary S. Gray, Donna Morris, Denise O'Hara, Paul R. Hinton, Naoya Tsurushita